Security record · archived quarter
CNTA
Centessa Pharmaceuticals plc · Healthcare · Biotechnology
11Tracked holders
0Δ holders
16.47MShares held
$236.89MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +6.2% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q1 2026 | 55 | +3 | 43.68M | $1.73B | +11 | −8 |
| Q4 2025 | 52 | -1 | 46.49M | $1.16B | — | −1 |
| Q3 2025 | 17 | 0 | 26.76M | $648.81M | +1 | −1 |
| Q2 2025 | 14 | +1 | 24.28M | $319.09M | +2 | −1 |
| Q1 2025 | 11 | 0 | 16.47M | $236.89M | — | — |
| Q4 2024 | 11 | -1 | 15.51M | $259.80M | — | −1 |
| Q3 2024 | 11 | +2 | 13.11M | $209.59M | +2 | — |
| Q2 2024 | 9 | — | 8.99M | $81.17M | — | — |
Who holds it · Q1 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 6.95M | +35.9% | $100.00M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 5.34M | -0.4% | $76.82M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Point72 Asset Management ✦ | 2.29M | -33.3% | $32.88M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 706.33K | +13.0% | $10.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 706.33K | +13.0% | $10.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Millennium Management ✦ | 609.19K | +52.9% | $8.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 178.00K | -0.3% | $2.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 138.77K | +20.6% | $2.00M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 138.77K | +20.6% | $2.00M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 138.77K | +20.6% | $2.00M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 136.03K | -2.6% | $1.96M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Marshall Wace ✦ | 136.03K | -2.6% | $1.96M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passive) | 60.44K | +5.6% | $869,141 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | State Street Global Advisors ✦ (passive) | 46.64K | -3.0% | $670,741 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 15.30K | -59.6% | $220,014 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 159 holders, 148.16M shares, $5.86B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q1 2025 ·
Methodology ·
Get this via the API